Search for: "Roche Holding AG"
Results 81 - 100
of 112
Sort by Relevance
|
Sort by Date
9 Apr 2009, 2:16 pm
A subsidiary Swiss drug maker of Roche Holding AG has announced a phased market withdraw of the injectable, psoriasis treatment drug, Raptiva because of Raptiva's link to a deadly brain disease. [read post]
9 Apr 2009, 12:34 pm
. -- which was just acquired by Roche Holding AG in March 2009 -- issued a press release announcing "a phased voluntary withdrawal of psoriasis drug Raptiva ® (efalizumab) from the U.S. market" due to its link to a brain infection, progressive multifocal leukoencephalopathy (PML). [read post]
6 Apr 2009, 8:20 am
., Roche Holding AG, Bayer AG, Johnson & Johnson, Forest Laboratories Inc., Eli Lilly & Co., Boehringer Ingelheim GmbH, Genentech Inc., GlaxoSmithKline Plc and Novartis AG. [read post]
5 Mar 2009, 11:46 pm
Visit Legal Technology
ADA Amendments Mean Employers Need to Be More Cautious
Texas Lawyer
By rejecting the narrow and exacting holdings in two U.S. [read post]
5 Feb 2009, 6:32 am
The FDA also said it was reviewing Roche Holding AG's (ROG.VX) diet drug, Xenical, for the risk of rectal bleeding to see whether any agency action was needed. [read post]
25 Jan 2009, 2:36 pm
A Pfizer-Wyeth agreement would exceed Roche Holding AG's $43.7 billion offer for the remainder of Genentech Inc., announced in July. [read post]
3 Oct 2008, 5:00 am
wsj.online noted: Amgen Inc. said a federal court granted the biotechnology company a permanent injunction prohibiting Roche Holding AG from selling its Mircera anemia treatment in the U.S., while also upholding a jury verdict regarding certain patent-infringement claims.The ruling represents a big victory for Amgen, whose anemia drugs Aranesp and Epogen accounted for more than 40% of its revenue last year. [read post]
2 Oct 2008, 12:36 pm
We've discussed the learned intermediary rule on this blog many times before - such as here, here, and here. [read post]
19 Sep 2008, 6:00 pm
: (IP finance), United States: An open letter for the General Counsel of the PTO on your San Diego presentation next week: (Hal Wegner), United States: Cocoa genome: breaking intellectual property barriers: (Thomson Reuters Scientific), Vietnam: Patentability of second medical use claims in Vietnam is again questionable: (Trung Truc JSC) Pharma & Biotech - Products Allegra (Fexofenadine) - Canada: Motion for summary judgment of noninfringement dismissed in patent infringement… [read post]
16 Aug 2008, 2:43 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Belgium - eBay wins ruling against L’Oreal in dispute over liability for counterfeit goods sold in online auctions: (Managing Intellectual Property), (Counterfeit Chic), (IPKat), (Class 46), (Techdirt), (Ars Technica) US CAFC holds that copying free software without complying with license is copyright infringement: Robert… [read post]
15 Aug 2008, 5:38 pm
Roche Holding AG is expected to increase its offer for the rest of Genentech by 21 percent to $53 billion. [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences: (Managing… [read post]
31 Jul 2008, 5:25 am
.'s longer-acting version of GlaxoSmithKline Plc's flu drug, Relenza, was as effective as a course of Tamiflu, a patient study found.The safety and efficacy of a single dose of the inhaled medicine was ``statistically indistinguishable'' from a twice-a- day dose of Roche Holding AG's Tamiflu taken for five days, said Melbourne-based Biota Holdings Ltd., which is developing the drug with Japan's Daiichi Sankyo. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
5 Jul 2008, 11:05 am
: (Spicy IP), Aspen pays £170M for IP rights to Eltroxin, Imuran, Lanoxin and Zyloric: (Afro-IP), Year after settling global patent feud over smallpox vaccine, Barvarian Nordic sues Oxford BioMedica over patents related to same virus: (IP Law360), Australia: Age reports former GSK executive’s victory in court action brought by GSK alleging he started a competing business using GSK’s confidential information: (IPwar’s), Brazil: ANVISA to review… [read post]
13 Jun 2008, 3:40 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ECJ rules trade mark holders cannot stop honest comparative advertising: O2 Holdings Limited and O2 (UK) Limited v Hutchinson 3G UK Limited: (Out-Law), (Catch Us If You Can!!!) [read post]
30 May 2008, 9:09 am
– Brdo: (IPR-Helpdesk), 5-6 June: USFDA public meeting on evaluation of product trade names: (FDA Law Blog), 5-7 June: European research and innovation exhibition – Paris: (IPR-Helpdesk), 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with… [read post]
2 May 2008, 7:00 am
Landmark IP implications for universities: University of Western Australia v Gray: (IPRoo), (Managing Intellectual Property), (The Age), Domain name transfer made easier: (Australian Trade Marks Law Blog), Quantum of obviousness in Australian patent laws - C Lawson: (IP Down Under), Separating Sony sheep from Grokster (and Kazaa) goats: Reckoning [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
